Rapid Micro Biosystems Shares Rise on Preliminary 4Q, FY Sales

Dow Jones

Jan 14

By Katherine Hamilton

Rapid Micro Biosystems shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates.

The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through the close shares were down 6.8% in the past three months.

The life sciences company said it expects fourth-quarter revenue to be $11.3 million, above the $11.2 million analysts polled by FactSet were projecting.

It anticipates full-year 2025 revenue will be $33.6 million, while analysts were looking for $33.5 million.

Rapid Micro plans to disclose its final results for the fourth quarter and full year at a later date. It is also scheduled to present at the J.P.Morgan healthcare conference on Thursday.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 13, 2026 17:48 ET (22:48 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603565529"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603565529\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603565529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 06:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603565529","market":"fut","top_or_hot":-1,"title":"Rapid Micro Biosystems Shares Rise on Preliminary 4Q, FY Sales","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/RPID\">Rapid Micro Biosystems</a> shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates. \n</p>\n<p>\n  The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through the close shares were down 6.8% in the past three months. \n</p>\n<p>\n  The life sciences company said it expects fourth-quarter revenue to be $11.3 million, above the $11.2 million analysts polled by FactSet were projecting. \n</p>\n<p>\n  It anticipates full-year 2025 revenue will be $33.6 million, while analysts were looking for $33.5 million. \n</p>\n<p>\n  Rapid Micro plans to disclose its final results for the fourth quarter and full year at a later date. It is also scheduled to present at the J.P.Morgan healthcare conference on Thursday. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 17:48 ET (22:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rapid Micro Biosystems Shares Rise on Preliminary 4Q, FY Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRapid Micro Biosystems Shares Rise on Preliminary 4Q, FY Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-14 06:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/RPID\">Rapid Micro Biosystems</a> shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates. \n</p>\n<p>\n  The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through the close shares were down 6.8% in the past three months. \n</p>\n<p>\n  The life sciences company said it expects fourth-quarter revenue to be $11.3 million, above the $11.2 million analysts polled by FactSet were projecting. \n</p>\n<p>\n  It anticipates full-year 2025 revenue will be $33.6 million, while analysts were looking for $33.5 million. \n</p>\n<p>\n  Rapid Micro plans to disclose its final results for the fourth quarter and full year at a later date. It is also scheduled to present at the J.P.Morgan healthcare conference on Thursday. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 17:48 ET (22:48 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RPID","symbol_name":"Rapid Micro Biosystems, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603565529","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603565529","pubTimestamp":1768344480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Rapid Micro Biosystems shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates.The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through the close shares were down 6.8% in the past three months.The life sciences company said it expects fourth-quarter revenue to be $11.3 million, above the $11.2 million analysts polled by FactSet were projecting.It anticipates full-year 2025 revenue will be $33.6 million, while analysts were looking for $33.5 million.Rapid Micro plans to disclose its final results for the fourth quarter and full year at a later date. It is also scheduled to present at the J.P.Morgan healthcare conference on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RPID":"Rapid Micro Biosystems, Inc."},"translate_title":"Rapid Micro Biosystems股价因财年第四季度初步销售额而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RPID":1.5},"content_text":"By Katherine Hamilton \n\n\n \n\n\nRapid Micro Biosystems shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates. \n\n\n  The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through the close shares were down 6.8% in the past three months. \n\n\n  The life sciences company said it expects fourth-quarter revenue to be $11.3 million, above the $11.2 million analysts polled by FactSet were projecting. \n\n\n  It anticipates full-year 2025 revenue will be $33.6 million, while analysts were looking for $33.5 million. \n\n\n  Rapid Micro plans to disclose its final results for the fourth quarter and full year at a later date. It is also scheduled to present at the J.P.Morgan healthcare conference on Thursday. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 17:48 ET (22:48 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}